Document:

Form of Warrant to Purchase Common Stock

 Exhibit 4.1 
 THE SECURITIES REPRESENTED BY THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR
SECURITIES LAWS OF ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE 1933 ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE 1933 ACT OR SUCH
LAWS. 
 POWERWAVE TECHNOLOGIES, INC. 
 FORM OF WARRANT TO PURCHASE COMMON STOCK 
 Warrant No.:
[        ] 
 Date of Issuance:
[            ], 20[    ] (“Date of Issuance”) 
 THIS CERTIFIES THAT, for value received, P-WAVE HOLDINGS, LLC (including any successors or assignees, “Holder”), is entitled to subscribe for and purchase at the Exercise Price (as
defined below) from Powerwave Technologies Inc., a Delaware corporation (the “Company”), up to [            ] shares of the common stock, par value $0.0001 per share, of
the Company (the “Common Stock”), subject to adjustment as provided herein. 
 This Warrant to Purchase Common
Stock (this “Warrant”) is issued pursuant to the terms of the Credit Agreement, dated as of September [    ], 2012, by and among the Company, as borrower, and the lenders signatory thereto and P-WAVE HOLDINGS,
LLC, as Agent (the “Credit Agreement”). Unless otherwise indicated, capitalized terms used in this Warrant shall have the respective meanings ascribed to such terms in the Credit Agreement. 

1. Definitions. As used herein, the following terms shall have the following respective meanings: 

“Board” shall mean the Board of Directors of the Company. 

“Convertible Securities” or “Convertible Security” means, collectively and individually, stock or
securities directly or indirectly convertible into or exercisable or exchangeable for shares of Common Stock. 

“Current Market Price Per Common Share” as of any date means the average of the Daily Prices per share of Common Stock
for the seven (7) consecutive Trading Days immediately prior to such date. 
 “Exercise Period” shall mean
the period commencing on the Date of Issuance and ending on September [    ], 2022. 
 “Exercise
Price” shall mean Fifty Cents ($0.50) per share, subject to adjustment pursuant to Section 5 below. 

  
 1 

 “Exercise Shares” shall mean the shares of the Company’s Common Stock
issued or issuable upon exercise of this Warrant, subject to adjustment pursuant to Section 5 below. 
 “Fair
Market Value” of Common Stock or any other security or property means the fair market value thereof as determined in good faith by the Board, which determination must be set forth in a written resolution of the Board, in accordance with the
following rules: (i) for securities traded or quoted on a Trading Market, the Fair Market Value will be the average of the closing prices of such security on such Trading Market over a seven (7) consecutive Trading Day period, ending on
the Trading Day immediately prior to the date of determination; (ii) for any securities that are not so traded or quoted, the Fair Market Value shall be determined by the Board; or (iii) for any other property, the Fair Market Value shall
be determined by the Board in good faith assuming a willing buyer and a willing seller in an arms’-length transaction. 

“Fundamental Change” means any of the following: (i) any merger, consolidation, stock or asset purchase,
recapitalization or other business combination transaction (or series of related transactions) as a result of which the shares of capital stock of the Company entitled to vote generally in the election of directors immediately prior to such
transaction (or series of related transactions) are converted into and/or thereafter represent, in the aggregate, less than 50% of the total voting power of all shares of capital stock that are entitled to vote generally in the election of directors
of the entity surviving or resulting from such transaction (or ultimate parent thereof), (ii) any person or group, together with any Affiliates thereof, has, directly or indirectly, become the beneficial owner of more than 50% of the total
voting power of all shares of capital stock of the Company that are entitled to vote generally in the election of directors (excluding the (a) upon the conversion or exchange of securities outstanding as of the Issuance Date and (b) shares
of capital stock issued by the Company in connection with a bona fide equity financing transaction (or series of related transactions)), (iii) the sale, transfer or disposition, including but not limited to any spin-off or in-kind distribution
of all or substantially all of the assets, business or securities of the Company (on a consolidated basis) to any person or group (other than the Company or one or more of its wholly-owned subsidiaries), (iv) the dissolution, liquidation or
winding up of the Company or (v) the Company effects any reorganization, recapitalization or reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property (excluding dividend issuances, stock splits, stock combination or similar transactions subject to Section 5.1(b). 
 “Trading Day” shall mean (i) a day on which the Common Stock is traded on a Trading Market, or (ii) if the Common Stock is not listed on a Trading Market, a day on which the
Common Stock is quoted on another established automated over-the-counter trading market in the United States of America (including the OTC Market or the OTC Bulletin Board); provided, that in the event the Common Stock is not listed or quoted
as set forth in (i) and (ii) hereof, then Trading Day shall mean a Business Day. 
 “Trading Market”
means The NASDAQ Global Market, The NASDAQ Global Select Market, The NASDAQ Capital Market, The NYSE MKT, or The New York Stock Exchange, Inc. 
 “VWAP” means, for any security as of any date, the dollar volume-weighted average price for such security on the applicable Trading Market during the period beginning at 9:30:01 a.m., New
York time (or such other time as such Trading Market publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as such Trading Market publicly announces is the official close of trading), as
reported by Bloomberg L.P. through its “Volume at Price” function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such
security during the period beginning at 9:30:01 a.m., New York time (or such other time as such Trading Market publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as such Trading Market

  
 2 

 
publicly announces is the official close of trading), as reported by Bloomberg L.P., or, if no dollar volume-weighted average price is reported for such security by Bloomberg L.P. for such hours,
the average of the highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the OTC Link or “pink sheets” by OTC Markets Group Inc. (formerly Pink OTC Markets Inc.). If the
VWAP cannot be calculated for a security on a particular date on any of the foregoing bases, the VWAP of such security on such date shall be the Fair Market Value as mutually determined by the Company and Holder. 

2. Exercise of Warrant. 

2.1 Method of Exercise. The rights represented by this Warrant may be exercised in whole or in part at any time during the
Exercise Period, by delivery of the following to the Company at its address set forth in Section 11 hereof (or at such other address as it may designate by notice in writing to Holder): 

(a) An executed Notice of Exercise in the form attached hereto; and 

(b) Payment of the Exercise Price either (i) in cash or wire transfer of immediately available funds or by cashier’s check
drawn down on a United States bank made payable to the order of the Company, or (ii) pursuant to a Cashless Exercise, as described in Section 2.2. 
 2.2 Cashless Exercise. Notwithstanding any provisions herein to the contrary, if, at any time during the Exercise Period, the Current Market Price (as defined below) of one share of Common Stock is
greater than the Exercise Price (at the date of calculation as set forth below), in lieu of exercising this Warrant by payment of cash, Holder may exercise this Warrant in whole or in part by a cashless exercise by surrender of this Warrant at the
principal office of the Company together with the properly endorsed Notice of Exercise and the Company shall issue to Holder a number of shares of Common Stock computed using the following formula: 

 

					
	 	 	X =	 	Y (B-A)
		 		 	      B
			
	Where:	 	X =	 	the number of shares of Common Stock to be issued to Holder.
			
		 	Y =	 	the number of shares of Common Stock purchasable upon exercise of all of the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being
exercised.
			
		 	A =	 	the Exercise Price.
			
		 	B =	 	the average of the closing prices for the Common Stock for the seven (7) Trading Days immediately prior to (but not including) the date of exercise (the “Current Market
Price”).

 For purposes of Rule 144 promulgated under the 1933 Act, it is intended, understood and acknowledged that the Exercise
Shares issued in a cashless exercise transaction shall be deemed to have been acquired by Holder, and the holding period for the Exercise Shares shall be deemed to have commenced, on the original Date of Issuance. 

2.3 Partial Exercise; Fractional Shares. If this Warrant is exercised in part only, the Company shall, upon surrender of this
Warrant, execute and deliver in accordance with Section 9, a new Warrant evidencing the rights of Holder or such other person as shall be designated in the Notice of Exercise, to 

  
 3 

 
purchase the balance of the Exercise Shares purchasable hereunder. In no event shall this Warrant be exercised for a fractional Exercise Share, and the Company shall not distribute a Warrant
exercisable for a fractional Exercise Share. Fractional shares shall be treated as provided in Section 6 hereof. 
 2.4
Payment of Expenses and Taxes. The Company shall pay all expenses in connection with, and all taxes and other governmental charges that may be imposed with respect to, the issue or delivery thereof, unless such tax or charge is imposed by law
upon Holder. 
 2.5 Delivery of Shares. Exercise Shares acquired hereunder shall be delivered to Holder within three
(3) Trading Days after any date on which this Warrant shall have been validly exercised in full or in part. The person in whose name any Exercise Shares are to be issued upon exercise of this Warrant shall be deemed to have become the holder of
record of such shares on the date on which this Warrant was validly exercised, irrespective of the date of issuance of the shares of Common Stock, except that, if the date of such valid exercise is a date when the stock transfer books of the Company
are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the stock transfer books are open. 
 3. Representations, Warranties and Covenants of the Company. 
 3.1 Due
Authority. The execution and delivery by the Company of this Warrant and the performance of all obligations of the Company hereunder, including the issuance of any Exercise Shares to Holder hereunder in accordance with the terms of this Warrant,
have been duly authorized by all necessary corporate action on the part of the Company. This Warrant: (a) does not violate the Company’s certificate of incorporation or bylaws (each as amended and in effect); (b) does not contravene
any law or governmental rule, regulation or order applicable to the Company; and (c) does not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument to which it is a party
or by which it is bound. This Warrant constitutes a legal, valid and binding agreement of the Company, enforceable in accordance with its terms. 
 3.2 Consents and Approvals. No consent or approval of, giving of notice to, registration with, or taking of any other action in respect of any state, federal or other governmental authority or
agency is required with respect to the execution, delivery and performance by the Company of its obligations under this Warrant, except for filings under applicable federal and state securities law, which filings will be effective by the time
required thereby. 
 3.3 Covenants as to Exercise Shares. The Company covenants and agrees that it will at all times
during the Exercise Period, have authorized and reserved, free from preemptive rights, a sufficient number of shares of its Common Stock to provide for the exercise of the rights represented by this Warrant. All Exercise Shares will, upon issuance,
be validly issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance thereof. If at any time during the Exercise Period the number of authorized but unissued shares of Common Stock
shall not be sufficient to permit exercise of this Warrant, the Company will take such corporate action as may, in the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as
shall be sufficient for such purposes. 
 3.4 No Impairment. Except and to the extent as waived or consented to by
Holder, the Company will not, by amendment of its certificate of incorporation or bylaws (as such may be amended from time to time), or through any means, avoid or seek to avoid the observance or performance of any of the terms to be observed or
performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all such action as may be necessary or appropriate in order to protect the exercise rights
of Holder against impairment. 

  
 4 

 3.5 Automatic Exercise. Notwithstanding anything herein to the contrary, to the
extent this Warrant remains exercisable as of such date, this Warrant shall be deemed to be fully exercised pursuant to Section 2.2, without the need for any action by Holder or the Company, immediately prior to the end of the Exercise Period.

 4. Beneficial Ownership. Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable by
Holder to the extent (but only to the extent) that Holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the Common Stock. To the extent the above limitation applies, the
determination of whether this Warrant shall be exercisable (vis-à-vis other convertible, exercisable or exchangeable securities owned by Holder or any of its affiliates) and of which such securities shall be exercisable (as among all such
securities owned by the Holder) shall, subject to such Maximum Percentage limitation, be determined on the basis of the first submission to the Company for conversion, exercise or exchange (as the case may be). No prior inability to exercise this
Warrant pursuant to this Section 4 shall have any effect on the applicability of the provisions of this Section 4 with respect to any subsequent determination of exercisability. For the purposes of this Section 4, beneficial ownership
and all determinations and calculations (including, without limitation, with respect to calculations of percentage ownership) shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (“1934
Act”) and the rules and regulations promulgated thereunder. This Section 4 shall only apply to the initial Holder and shall not apply to any successor Holder of this Warrant unless such successor Holder is an affiliate of the initial
Holder. For any reason at any time, upon the written or oral request of the Holder, the Company shall within two (2) Business Days confirm orally and in writing to Holder the number of shares of Common Stock then outstanding, including by
virtue of any prior conversion or exercise of convertible or exercisable securities into Common Stock, including, without limitation, pursuant to this Warrant. By written notice to the Company, Holder may increase or decrease the Maximum
Percentage to any other percentage not in excess of 9.99% specified in such notice; provided that any such increase will not be effective until the 61st day after such notice is delivered to the Company. 

5. Certain Adjustments. 

5.1 Certain Adjustments. 
 (a) Adjustments for Issuances of Additional Shares of Common Stock. 
 (i) Definitions. For purposes of this Section 5.1(a), the following definitions apply: 
 (1) “Additional Shares of Common Stock” means any shares of Common Stock issued (whether from the Company’s treasury or authorized and unissued shares of capital stock) or, as
provided in Section 5.1(a)(ii) below, deemed to be issued by the Company after the Closing Date; provided, that, notwithstanding anything to the contrary contained herein, Additional Shares of Common Stock shall not include issuances of
Common Stock (including any deemed issuance pursuant to Section 5.1(a) (ii)) which are (A) pursuant to employee benefit plans and compensation related arrangements approved by the board of directors of the Company (including any duly
authorized committee or delegee thereof), (B) in connection with any acquisition of assets, merger, consolidation or other combination of the Company or a Subsidiary of the Company with another person, or (C) which are subject to Sections
5.1(b) and (c). 
 (2) “Measurement Date” means, with respect to a transaction, the public
announcement of such transaction (or, if no such public announcement is made, the date of issuance). 

  
 5 

 (ii) Deemed Issuances of Additional Shares of Common Stock. The
maximum number of shares of Common Stock (as set forth in the instrument relating thereto without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise, conversion or exchange of Convertible
Securities will be deemed to be Additional Shares of Common Stock issued as of the time of the issuance of such Convertible Securities; provided, however, that: 

(1) No adjustment in the Exercise Price will be made upon the subsequent issuance of shares of Common Stock upon the
exercise, conversion or exchange of such Convertible Securities; 
 (2) To the extent that Additional Shares of
Common Stock are not issued pursuant to any such Convertible Security upon the expiration or termination of an unissued, unexercised, unconverted or unexchanged Convertible Security, the Exercise Price will be readjusted to the Exercise Price that
would have been in effect had such Convertible Security (to the extent outstanding immediately prior to such expiration or termination) never been issued; and 
 (3) In the event of any change in the number of shares of Common Stock issuable upon the exercise, conversion or exchange of any Convertible Security, excluding a change resulting from any transaction
giving rise to an adjustment pursuant to Section 5.1(b), but including periodic or scheduled accretions or adjustments to a Convertible Security, interest and dividends paid in kind, repricings of the exercise or conversion price of such
Convertible Securities or otherwise, the Exercise Price then in effect will be readjusted to the Exercise Price that would have been in effect if, on the date of issuance, such Convertible Security were exercisable, convertible or exchangeable for
such changed number of shares of Common Stock. 
 (iii) Determination of Consideration. The Fair Market
Value of the consideration received by the Company for the issue of any Additional Shares of Common Stock will be computed as follows: 
 (1) Cash and Property. Aggregate consideration consisting of cash, cash equivalents and other property will: (x) insofar as it consists of cash or cash equivalents (including the satisfaction
of the liquidated portion of liabilities), be computed at the aggregate amount of cash or cash equivalents received by the Company or paid (or deemed paid, including the satisfaction of liabilities) by or on behalf of the Company excluding amounts
paid or payable for accrued interest or accrued dividends; (y) insofar as it consists of property other than cash, be computed at the Fair Market Value thereof on the Measurement Date; and (3) insofar as it consists of both cash and other
property, be the proportion of such consideration so received. 
 (2) Convertible Securities. The
aggregate consideration per share received by the Company for Convertible Securities will be determined by dividing: (x) the total amount, if any, received or receivable by the Company as consideration for the issuance of such Convertible
Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Company
upon the full and complete exercise, conversion or exchange of such Convertible Securities, by (y) the maximum number of shares of Common Stock (as set forth in the instruments relating thereto, without regard to any provision contained therein
for a subsequent adjustment of such number) issuable upon the full and complete exercise, conversion or exchange of such Convertible Securities. 

  
 6 

 (iv) Below Exercise Price Issuance. In the event the Company shall,
at any time and from time to time while any of the Warrants are outstanding, issue or sell Additional Shares of Common Stock for a consideration per share, as determined by such consideration’s Fair Market Value in accordance with
Section 5.1(a)(iii), less than the Exercise Price in effect immediately prior to such issuance (a “Below Exercise Price Issuance”), then, effective immediately upon the date of such Below Exercise Price Issuance, the Exercise
Price in effect immediately after such Below Exercise Price Issuance shall be reduced so that the same shall equal the price determined by multiplying the Exercise Price in effect immediately prior to such Below Exercise Price Issuance by a
fraction: (1) the numerator of which shall be the sum of (a) the number of shares of Common Stock outstanding immediately prior to such Below Exercise Price Issuance (on a fully diluted basis, including the aggregate number of shares of
Common Stock issuable upon exercise of the all Convertible Securities, based on the treasury method) (such number of shares of Common Stock, the “Number of Fully Diluted Shares of Common Stock”); plus (b) (x) the Fair
Market Value of the aggregate consideration received by the Company in respect of such Below Exercise Price Issuance, divided by (y) the Exercise Price in effect immediately prior to such Below Exercise Price Issuance, and (2) the
denominator of which shall be the sum of (a) the Number of Fully Diluted Shares of Common Stock, plus (b) the number of such Additional Shares of Common Stock issued in such Below Exercise Price Issuance. 

(v) NASDAQ Savings Clause. If any adjustment pursuant to Section 5.1(a)(iv) results in an adjustment to the
number of Exercise Shares pursuant to Section 5.1(d) that would require the Company to issue shares of Common Stock in excess of the amount permitted to be issued without approval by the Company’s stockholders by the applicable listing
standards of The NASDAQ Global Select Market or other Trading Market on which the Common Stock is then listed, the Company shall, at its option, either (i) obtain the approval of its stockholders with respect to such issuance in accordance with
the applicable rules of such Trading Market or (ii) in lieu of delivering shares of Common Stock in excess of such limitations, pay cash on a pro rata basis to the holders of the Warrants being exercised in an amount per share of Common Stock
equal to the VWAP of the Common Stock for the Trading Day immediately preceding the date of such conversion in respect of which such shares would otherwise be required to be delivered to the holders of the exercised Warrants and which are not
permitted to be issued and so delivered by such listing standards. 
 (b) Stock Dividends and Splits. If the Company, at
any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides outstanding shares of
Common Stock into a larger number of shares, or (iii) combines outstanding shares of Common Stock into a smaller number of shares, then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the
number of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment pursuant to clause (i), (ii) or
(iii) of this paragraph shall become effective immediately upon the effective date of such dividend or distribution, subdivision or combination. 
 (c) Fundamental Change. If, at any time while any portion of this Warrant is outstanding there is a Fundamental Change, then Holder shall thereafter receive, upon exercise of this Warrant following
the Fundamental Change, the same amount of securities, cash or property as it would 

  
 7 

 
have been entitled to receive upon the occurrence of such Fundamental Change if it had been, immediately prior to such Fundamental Change, the holder of the number of Exercise Shares then
issuable upon exercise in full of this Warrant (the “Alternate Consideration”) (in lieu of the Exercise Shares if the Exercise Shares would no longer be outstanding as a result of such Fundamental Change had they been outstanding
immediately prior thereto). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one
share of Common Stock in such Fundamental Change, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
Any successor to the Company or surviving entity in such Fundamental Change shall issue to Holder a new warrant substantially in the form of this Warrant and consistent with the foregoing provisions and evidencing Holder’s right to purchase the
Alternate Consideration for the aggregate Exercise Price upon exercise thereof and, upon such issuance, this warrant shall be automatically cancelled and shall cease to be of further force or effect. The terms of any agreement pursuant to which a
Fundamental Change is effected shall include terms requiring any such successor or surviving entity to comply with the provisions of this paragraph (c). 
 (d) Number of Exercise Shares. Simultaneously with any adjustment to the Exercise Price pursuant to this Section 5, the number of Exercise Shares that may be purchased upon exercise of this
Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Exercise Shares shall be the same as the aggregate Exercise Price in effect immediately
prior to such adjustment. 
 (e) Calculations. All calculations under this Section 5 shall be made to the nearest
cent or the nearest 1/100th of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company, and the disposition of any such shares shall be
considered an issue or sale of Common Stock. 
 (f) Notice of Adjustments. Upon the occurrence of each adjustment
pursuant to this Section 5, the Company at its expense will within five (5) Business Days compute such adjustment in accordance with the terms of this Warrant and prepare a notice setting forth such adjustment, including a statement of the
adjusted Exercise Price and adjusted number or type of Exercise Shares or other securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts upon which
such adjustment is based. Upon written request, the Company will deliver a copy of each such notice to Holder and to the Company’s transfer agent. 
 (g) Notice of Corporate Events. If the Company (i) declares a dividend or any other distribution of cash, securities or other property in respect of its Common Stock, including without
limitation any granting of rights or warrants to subscribe for or purchase any capital stock of the Company or any Subsidiary, (ii) authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any
Fundamental Change or (iii) authorizes the voluntary dissolution, liquidation or winding up of the affairs of the Company, then the Company shall deliver to Holder a notice describing the material terms and conditions of such transaction at
least 10 calendar days prior to the applicable record or effective date on which a person would need to hold Common Stock in order to participate in or vote with respect to such transaction, and the Company will take all steps reasonably necessary
in order to insure that Holder is given a reasonable opportunity to exercise this Warrant prior to such time so as to participate in or vote with respect to such transaction; provided, however, that the failure to deliver such notice
or any defect therein shall not affect the validity of the corporate action required to be described in such notice. 

  
 8 

 6. Fractional Shares. No fractional shares shall be issued upon the exercise of this Warrant as a
consequence of any adjustment pursuant hereto. All Exercise Shares (including fractions) issuable upon exercise of this Warrant may be aggregated for purposes of determining whether the exercise would result in the issuance of any fractional share.
If, after aggregation, the exercise would result in the issuance of a fractional share, the Company shall, in lieu of issuance of any fractional share, pay Holder otherwise entitled to such fraction a sum in cash equal to the product resulting from
multiplying the then current Fair Market Value of an Exercise Share by such fraction. 
 7. No Stockholder Rights. This Warrant in and of
itself shall not entitle Holder to any voting rights or other rights as a stockholder of the Company. 
 8. Successors and Assigns. This
Warrant applies to, inures to the benefit of and binds the successors and assigns of the parties hereto. 
 9. Transfer; Reissuance of
Warrant. 
 (a) Transfer of Warrant. Subject to compliance with applicable federal and state securities laws,
this Warrant and all rights hereunder are transferable in whole or in part by the Holder. Holder may transfer (without the need for an opinion of counsel) this Warrant and any Warrant Shares to its Affiliates. If this Warrant is to be transferred in
whole or in part, Holder shall surrender this Warrant to the Company, whereupon the Company will forthwith issue and deliver upon the order of Holder a new Warrant (in accordance with this Section 9), registered as Holder may request,
representing the right to purchase the number of Exercise Shares being transferred by Holder and, if less than the total number of Exercise Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with
Section 9(d)) to Holder representing the right to purchase the number of Exercise Shares not being transferred. Any attempted transfer of this Warrant in whole or in part not complying with this Section 9 shall be null and void and, in
such case, the transferor Holder shall remain the Holder for purposes of this Warrant. 
 (b) Lost, Stolen or Mutilated
Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, the Company shall execute and deliver to Holder a new Warrant (in accordance with
Section 9(d)) representing the right to purchase the Exercise Shares then underlying this Warrant. 

(c) Exchangeable for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by Holder at the principal
office of the Company, for a new Warrant or Warrants (in accordance with Section 9(d)) representing in the aggregate the right to purchase the number of Exercise Shares then underlying this Warrant, and each such new Warrant will represent the
right to purchase such portion of such Exercise Shares as is designated by Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall be given. 

(d) Issuance of New Warrants. Whenever the Company is required to issue a new Warrant or Warrants pursuant to the terms of
this Warrant, each new Warrant (i) shall be issued by the Company within three (3) Trading Days of receiving instructions from Holder in accordance with this Warrant, (ii) shall be of like tenor with this Warrant, (iii) shall
represent, as indicated on the face of such new Warrant, the right to purchase the Exercise Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 9(a) or Section 9(c), the Exercise Shares
designated by Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Exercise Shares then underlying this Warrant), (iv) shall
have an issuance date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (v) except as provided in the foregoing clause (iii), shall have the same rights and conditions as this Warrant. 

  
 9 

 10. Modifications and Waiver. This Warrant and any provision hereof may be waived, modified or
amended only by an instrument in writing signed by the Company and Holder. 
 11. Notices. Any notices or other communications required
or permitted to be given hereunder shall be in writing and shall be deemed to be given when delivered in person or by private courier with receipt, if faxed when verbal or email confirmation from the recipient is received, or three (3) days
after being deposited in the United States mail, first-class, registered or certified, return receipt requested, with postage paid. All communications shall be sent to the Company and the initial Holder at the addresses set forth in the Credit
Agreement and to any successor Holder at such address indicated in writing to the Company by such Holder. The Company and Holder may change the address to which notices and communications to it are to be addressed by notification as provided herein.

 12. Acceptance. Receipt of this Warrant by Holder shall constitute acceptance of and agreement to all of the terms and conditions
contained in this Warrant. 
 13. Governing Law. 
 (a) This Warrant shall be governed by, and construed in accordance with, the laws of the State of Delaware. 
 (b) The Company and Holder each hereby irrevocably and unconditionally: (i) submits for itself and its property in any legal action or proceeding relating solely to this Warrant or the transactions
contemplated hereby, to the exclusive jurisdiction of the courts of the State of Delaware and the Federal courts of the United States of America located within the State of Delaware, and appellate courts thereof; (ii) consents that any such
action or proceeding may be brought in such courts, and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and
agrees not to plead or claim the same to the extent permitted by applicable law; (iii) agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any
substantially similar form of mail), postage prepaid, to the party, as the case may be, at its address set forth in Section 11 or at such other address of which the other party shall have been notified pursuant thereto; (iv) agrees that
nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction for recognition and enforcement of any judgment or if jurisdiction in the courts
referenced in the foregoing clause (i) are not available despite the intentions of the parties hereto; (v) agrees that final judgment in any such suit, action or proceeding brought in such a court may be enforced in the courts of any
jurisdiction to which such party is subject by a suit upon such judgment, provided that service of process is effected upon such party in the manner specified herein or as otherwise permitted by law; (vi) agrees that to the extent that such
party has or hereafter may acquire any immunity from jurisdiction of any court or from any legal process with respect to itself or its property, such party hereby irrevocably waives such immunity in respect of its obligations under this Warrant, to
the extent permitted by law; and (vii) irrevocably and unconditionally waives trial by jury in any legal action or proceeding in relation to this Warrant. 
 14. Descriptive Headings. The descriptive headings of the several paragraphs of this Warrant are inserted for convenience only and do not constitute a part of this Warrant. The language in this
Warrant shall be construed as to its fair meaning without regard to which party drafted this Warrant. 
 15. Severability. If any part or
provision of this Warrant is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent
possible, the original business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Warrant shall remain binding upon the parties hereto. 

  
 10 

 16. Entire Agreement. This Warrant and the other Loan Documents constitute the entire agreement
between the parties pertaining to the subject matter hereof and supersedes all prior agreements, negotiations, understandings, representations, and statements with respect to the subject matter hereof, whether written or oral. 

17. Indemnification. The Company shall indemnify, save and hold harmless Holder from and against any and all liability, loss, cost, damage,
reasonable attorneys’ and accountants’ fees and expenses, court costs and all other out of-pocket expenses incurred in connection with or arising from any default hereunder by the Company. This indemnification provision shall be in
addition to the rights of such Holder to bring an action against the Company for breach of contract based on such default hereunder. 
 18.
Limitation of Liability. No provision hereof, in the absence of affirmative action by Holder to purchase shares of Common Stock, and no enumeration herein of the rights or privileges of Holder hereof, shall give rise to any liability of such
Holder to pay the Exercise Price for any Exercise Shares other than pursuant to an exercise of this Warrant or any liability as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 19. Remedies. In addition to being entitled to exercise its rights granted by law, including recovery of damages, Holder shall be
entitled to specific performance of its rights provided under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby
agrees, in an action for specific performance, to waive the defense that a remedy at law would be adequate. 
 20. Further Acts. Each of
the parties hereto agrees to perform any further acts and execute and deliver any documents that may be reasonably necessary to carry out the provisions of this Warrant. 
 [Signature Page Follows] 

  
 11 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly
authorized officer as of the date first written above. 
  

					
	POWERWAVE TECHNOLOGIES, INC.
		
	 By:
	 	  

		 	 Name:
	 	  

		 	 Title:
	 	  

  
 12 

 NOTICE OF EXERCISE 

 

	TO:	POWERWAVE TECHNOLOGIES, INC. 

 The undersigned (“Holder”) elects to acquire shares of Common Stock of Powerwave Technologies, Inc. (the “Company”), pursuant to the terms of the Warrant. 

(1) The undersigned hereby elects to (check one box only): 

 ̈  purchase           
  shares of the Common Stock pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full for such shares. 
  ̈  purchase the number of shares of Common Stock of the Company by cashless exercise pursuant to the terms of the Warrant as shall be issuable
upon cashless exercise of the portion of the Warrant relating to             shares. 
 (2) Please issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned (or in such other name as is specified below) and, if applicable, issue a new
Warrant in like tenor representing the right to purchase             shares of Common Stock under the attached Warrant not being purchased at this time under this Notice of Exercise,
in each case as specified below by Holder: 
  

			
		 	  

		 	  

		 	  

  

							
	 	 	HOLDER:	 	  

		 		 	(Print name)
			
		 	By:	 	  

	Date:             , 20        	 		 	Name:	 	  

		 		 	Title:	 	  

  
 13 

 ASSIGNMENT FORM 
 (To assign the foregoing Warrant, subject to compliance with Section 9 thereof, execute this form and supply required information. Do not use this form to purchase shares.) 

FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to: 

 

	
	Name of transferee:
	  

	(Print name)
	
	Address:
	  

	  

	  

  

							
		 	HOLDER:	 	  

		 		 	(Print name)
			
	Date:            ,20    	 	By:	 	  

		 		 	Name:	 	  

		 		 	Title:	 	  

  
 14Registration Rights Agreement

 Exhibit 4.2 
 POWERWAVE TECHNOLOGIES, INC. 
 REGISTRATION RIGHTS AGREEMENT

 This Registration Rights Agreement (this “Agreement”) is made and entered into this 11th day of
September 2012, among Powerwave Technologies, Inc., a Delaware corporation (the “Company”), and the lenders signatory thereto and P-WAVE HOLDINGS, LLC, as Agent (the “Lender Parties”). . 

This Agreement is being made pursuant to (i) the Credit Agreement, dated as of September 11, 2012, by and among the Company, as
borrower, and the Lender Parties (the “Credit Agreement”) and (ii) the Warrants issued on the Closing Date and from time to time pursuant to Section 2.03 of the Credit Agreement. Unless otherwise indicated, capitalized
terms used in this Agreement shall have the respective meanings ascribed to such terms in the Credit Agreement. 
 In order to
induce the Initial Holders to enter into the Credit Agreement, the Company has agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is required pursuant to Section 4.01 of the Credit Agreement.

 In consideration of the foregoing, the parties hereto agree as follows: 

1. Definitions. As used in this Agreement, the following capitalized defined terms shall have the following meanings: 

“1933 Act” shall mean the Securities Act of 1933, as amended. 

“1934 Act” shall mean the Securities Exchange Act of 1934, as amended. 

“Affiliate” shall mean, with respect to any Person, any other Person controlling, controlled by or under direct or
indirect common control with such Person. For the purposes of this definition, “control” when used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of such Person (whether through the ownership of voting securities, by contract or otherwise), and the terms “controlling” and “controlled” have meanings correlative to the foregoing. 

“Agreement” shall have the meaning set forth in the preamble hereof. 

“Beneficially Own” or “Beneficial Ownership” shall have the meaning set forth in Rule 13d-3 of the
rules and regulations promulgated under the 1934 Act. 
 “Common Stock” shall mean any shares of Common Stock,
$0.0001 par value, of the Company. 
 “Company” shall have the meaning set forth in the preamble hereof and
shall also include the Company’s successors. 
 “Credit Agreement” shall have the meaning set forth in the
preamble. 
 “Effectiveness Period” shall mean the period from the date of this Agreement until such time as
there are no longer any Registrable Securities outstanding or issuable upon the exercise of Warrants. 
 “Excluded
Registration” shall mean (i) a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; or (ii) a registration relating to an SEC Rule
145 transaction. 

  
 1 

 “Free Writing Prospectus” shall have the meaning set forth in Rule 405 of
the 1933 Act. 
 “Holder” and “Holders” shall mean, individually and collectively, the holders
of any Registrable Securities, and each of their respective successors, assigns and direct and indirect transferees who Beneficially Own the Registrable Securities. 
 “Initial Holders” shall mean the initial holder or holders of any Warrants. 
 “Issuer Free Writing Prospectus” shall have the meaning set forth in Rule 433 of the 1933 Act. 
 “Lender Parties” shall have the meaning set forth in the preamble. 
 “Majority Holders” shall mean Holders holding over 50% of the Registrable Securities at such time (determined solely with reference to shares of Common Stock based on the number of shares
of Common Stock previously issued and remaining issuable under the then outstanding Warrants). 
 “Person”
shall mean an individual, partnership (general or limited), corporation, limited liability company, trust, unincorporated organization or other entity, or a government or agency or political subdivision thereof. 

“Prospectus” shall mean a prospectus relating to the Registrable Securities included in a Registration Statement,
including any preliminary prospectus, and any such prospectus as amended or supplemented by any prospectus supplement, including any such prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities
covered by a Registration Statement, and by all other amendments and supplements to a prospectus, including post-effective amendments, and in each case including all materials incorporated by reference therein. 

“Registrable Securities” shall mean the Warrant Shares; provided, however, that such Warrant Shares shall
cease to be Registrable Securities when (i) a Registration Statement with respect to such Warrant Shares shall have become effective under the 1933 Act and such Warrant Shares shall have been sold or transferred pursuant to such Registration
Statement, or (ii) such Warrant Shares have been transferred in compliance with Rule 144 under the 1933 Act (or any successor provision thereto). 
 “Registration and Offering Expenses” shall mean any and all expenses incident to performance of or compliance by the Company with this Agreement, including without limitation:
(i) all SEC registration and filing fees, (ii) as applicable, all reasonable fees and expenses incurred in connection with compliance with state securities or blue sky laws (including reasonable fees and disbursements of counsel for any
Underwriters or Holders in connection with blue sky qualification of any of the Registrable Securities), (iii) all expenses of the Company in preparing or assisting in preparing, word processing, printing and distributing any Registration
Statement and any Prospectus, and, as applicable, any offering or information memorandum, any amendments or supplements thereto, any securities sales agreements and any other documents relating to the performance of and compliance with this
Agreement, (iv) all fees and expenses incurred in connection with the listing, if any, of any of the Registrable Securities on any securities exchange or exchanges, (v) the fees and disbursements of counsel for the Company and of the
independent public accountants of the Company, (including, as applicable, the expenses of any “comfort letters”), (vi) the reasonable fees and expenses of any escrow agent or custodian, and (vii) the reasonable fees and expenses
of counsel to Holders in connection with the Registration Statement, which counsel shall be selected by the Majority Holders, but excluding any underwriting discounts, commissions and fees of any underwriters, selling brokers, dealer managers or
similar securities industry professionals and transfer taxes, if any, relating to the sale or disposition of Registrable Securities by a Holder. 

  
 2 

 “Registration Statement” shall mean a registration statement of the Company
pursuant to the provisions of Section 2 which covers Registrable Securities on Form S-1 or, if the Company is eligible to use Form S-3, Form S-3 under the 1933 Act, or any similar rule that may be adopted by the SEC, and all amendments
and supplements to such registration statement, including post-effective amendments, in each case including the Prospectus contained therein, all exhibits thereto and all materials incorporated by reference therein; provided, however,
that a registration statement shall not be deemed a Registration Statement until such time as it includes a Prospectus relating to the Registrable Securities. 
 “Rule 144” shall mean Rule 144 under the 1933 Act. 

“SEC” shall mean the Securities and Exchange Commission or any successor agency or government body performing the
functions currently performed by the United States Securities and Exchange Commission. 
 “Suspension Period”
shall have the meaning set forth in Section 2.2(b). 
 “Underwriter” shall mean an underwriter, as
defined in the 1933 Act, of the Registrable Securities in connection with an offering thereof under a Registration Statement. 

“Warrants” shall have the meaning set forth in the preamble. 

“Warrant Shares” means the shares of Common Stock issuable upon exercise of the Warrants (including any Common Stock or
other securities issued or issuable, directly or indirectly in respect of the Warrants or outstanding Warrant Shares by way of a spin-off, split-off, dividend, distribution or stock split or in connection with a combination of shares,
reclassification, merger, consolidation or reorganization or other similar event and any securities issued in replacement of or exchange for any securities). 
 2. Registration Under the 1933 Act. 
 2.1 Mandatory Registration.

 (a) The Company shall prepare and as promptly as possible after the date hereof, but in any event, not later than forty
five (45) days from the Closing Date (or, if such 45th day is not a Business Day, by the first Business Day thereafter) (the “Required Filing Date”), file a Registration Statement with respect to the Registrable Securities with
the SEC (the “Required Registration Statement”) and shall use its reasonable best efforts to cause the Required Registration Statement to be declared effective under the Securities Act within 90 days after the Closing Date (or, if
such 90th day is not a Business Day, by the first Business Day thereafter). If the Required Registration Statement is not filed with the SEC by the Required Filing Date, other than due to failure by a Holder to furnish information or consents
required under the 1933 Act or the rules and regulations promulgated thereunder to be included in the Required Registration Statement (including by means of a related questionnaire in a customary form reasonably acceptable to the Company
(“Questionnaire”), the Company shall pay Holders in cash an aggregate amount equal to $75,000 (the “Registration Delay Amount”) and, until such time that such filing has occurred, shall pay an additional
Registration Delay Amount for each thirty (30) day period following the Required Filing Date, such amounts shall be payable by the tenth (10th) day after the end of each such thirty (30) day period, shall be allocated among such
Holders in proportion (as nearly as practicable) to the number of Registrable Securities owned by each Holder or in such other proportion as shall mutually be agreed to by all such Holders, and shall be Holders’ sole remedy for such failure
(other than any equitable remedies available to such Holder, such as specific performance). The past due amounts payable to each Holder pursuant to this Section shall bear interest at a rate of the lesser of twelve percent (12%) per annum,
compounded annually, or the maximum rate then permitted by applicable law.

  
 3 

 (b) The Company shall use its commercially reasonable efforts to keep the Required
Registration Statement continuously effective for the Effectiveness Period commencing on the date the Required Registration Statement first becomes effective and, if requested in writing by the Majority Holders, shall, within fifteen (15) days
of such request, amend the Required Registration Statement to include (if applicable) any Registrable Securities relating to Warrants issued by the Company after the date the Required Registration Statement first became effective that were not
previously included in the Required Registration Statement. Except with the prior written consent of the Majority Holders, the Company may not include in the Required Registration Statement any securities other than the Registrable Securities.

 2.2 Demand Registration. 
 (a) If at any time the Company receives a request to file a Registration Statement, a completed Questionnaire and the other information required under this Agreement from Holders holding a majority of the
Registrable Securities then outstanding (the “Initiating Holders”), then the Company shall (i) within 10 Business Days give written notice thereof (the “Demand Notice”) to all Holders other than the Initiating
Holders, (ii) as soon as practicable, and in any event within 75 days after the date such request is given by the Initiating Holders, file a Registration Statement with the SEC covering all Registrable Securities that the Initiating Holders
requested to be registered and any additional Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such other Holder delivered to the Company within 20 days of the date the
Demand Notice is given, and in each case, subject to the limitations of Section 2.2(b), and (iii) at its own cost, use its reasonable best efforts to cause such Registration Statement to become effective as soon as practicable. 

(b) Notwithstanding the foregoing obligations, the Company may suspend the use of any Prospectus for a period not to exceed 75 days in
any 90-day period or an aggregate of 120 days in any 12-month period (each, a “Suspension Period”), if the Company shall have determined in good faith that, because of valid business reasons (not including avoidance of the
Company’s obligations hereunder), including, without limitation, plans for a registered public offering, an acquisition or other proposed or pending corporate developments and similar events because of filings with the SEC or any events
described in Section 3(h), it is in the best interests of the Company to suspend such use; provided, that (i) the Company may not suspend such use more than once in any 12-month period, and (ii) prior to suspending such use the
Company provides Holders with written notice of such suspension, which notice need not specify the nature of the event giving rise to such suspension (and each Holder agrees not to sell any Registrable Securities pursuant to the Registration
Statement until such Holder is advised in writing that the Prospectus may be used, which notice the Company agrees to provide promptly following the lapse of the event or circumstances giving rise to such suspension). Each Holder shall keep
confidential any communications received by it from the Company regarding the suspension of the use of the Prospectus (including, without limitation, the fact of the suspension), except as required by applicable law. 

(c) The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Section 2.2(a)
(i) during the period that is 30 days before the Company’s good faith estimate of the date of filing of, and ending on a date that is 90 days after the effective date of, a Company-initiated registration pursuant to which Holders had an
opportunity to register Registrable Securities pursuant to Section 2.3; provided, that the Company is actively employing in good faith reasonable efforts to cause such registration statement to become effective, or (ii) if the Company has
effected two (2) registrations pursuant to Section 2.2(a). Notwithstanding anything in Section 2.2 to the 

  
 4 

 
contrary, the Company shall not be required to effect more than one registration pursuant to Section 2.2(a) during the period from the date hereof through the one year anniversary of the
date hereof. A registration shall not be counted as “effected” for purposes of this Section 2.2(c) until such time as the applicable registration statement has been declared effective by the SEC. 

(d) It shall be a condition precedent to the obligation of the Company to take any action pursuant to this Section 2 with respect to
the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended method of disposition of such securities as is reasonably
required to effect the registration of such Holder’s Registrable Securities and as may be reasonably requested by the Company from time to time. 
 2.3 Company Registration. If the Company proposes to register (including, for this purpose, a registration effected by the Company for stockholders other than Holders) any of its Common Stock under
the 1933 Act in connection with the public offering of such securities solely for cash (other than in an Excluded Registration), the Company shall, at such time, promptly give each Holder notice of such proposed registration. Upon the request of
each Holder given within ten (10) Business Days after such notice is given by the Company, the Company shall, subject to the provisions of Section 3, cause to be registered all of the Registrable Securities that each such Holder has
requested to be included in such registration. With respect to any Registrable Securities that Holders do not request to be included in such registration, Holders agree not to sell, offer or agree to sell, grant any option for the sale of, or
otherwise transfer or dispose of securities of the same type (including any underlying securities) as the Registrable Securities included in such registration, or any securities convertible into or exercisable for such securities, during the ten
days prior to the pricing of the public offering related to such registration and until the earlier of (A) if applicable, the end of any lock-up period which the Underwriters deem is necessary to effectuate such public offering (which in no
event will be greater than 90 days plus such additional period as may be reasonably requested by the Company or Underwriters to accommodate regulatory restrictions on (i) the publication or other distribution of research reports or
(ii) analysts recommendations or opinions)), which lock-up period shall begin on the date of the pricing of such public offering, and (B) two (2) days following the abandonment of such public offering. The Company shall have the right
to terminate or withdraw any registration initiated by it under this Section 2.3 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration. 

2.4 Expenses. The Company shall pay all Registration and Offering Expenses in connection with any registration pursuant to this
Agreement. Each Holder shall pay all underwriting and placement discounts and commissions, agency and placement fees, brokers commissions and transfer taxes, if any, relating to the sale or disposition of such Holder’s Registrable Securities in
accordance with such Holder’s pro rata basis of the number of Registrable Securities to be registered on their behalf. 

2.5 Underwriting Requirements. 
 (a) If, pursuant to Section 2.2, the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a
part of their request made pursuant to Section 2.2, and the Company shall include such information in the Demand Notice. In cases other than a registration pursuant to Section 2.3, the Underwriters will be selected by a majority in
interest of the Initiating Holders and shall be reasonably acceptable to the Company. In a registration pursuant to Section 2.3, the Underwriters will be selected by the Company. In any such event, the right of any Holder to include such
Holder’s Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided
herein. All 

  
 5 

 
Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in Section 3(m)) enter into an underwriting agreement in customary
form with the Underwriters selected for such underwriting. Notwithstanding any other provision of this Section 2.5, if the managing Underwriters advise the Initiating Holders in writing that marketing factors require a limitation on the number
of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that otherwise would be underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting
shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of Registrable Securities owned by each Holder or in such other proportion as shall mutually be
agreed to by all such selling Holders; provided, however, that the number of Registrable Securities held by Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the
underwriting. To facilitate the allocation of shares in accordance with the above provisions, the Company or the Underwriters may round the number of shares allocated to any Holder to the nearest 100 shares. 

(b) In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Section 2.3,
the Company shall not be required to include any of Holders’ Registrable Securities in such underwriting unless Holders accept the terms of the underwriting as agreed upon between the Company and its Underwriters, and then only in such quantity
as the Underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in such offering
exceeds the number of securities to be sold (other than by the Company) that the Underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering only
that number of such securities, including Registrable Securities, which the Underwriters and the Company in their good faith discretion determine will not jeopardize the success of the offering. If the Underwriters determine that less than all of
the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable to) the
number of Registrable Securities owned by each selling Holder or in such other proportions as shall mutually be agreed to by all such selling Holders. To facilitate the allocation of shares in accordance with the above provisions, the Company or the
Underwriters may round the number of shares allocated to any Holder to the nearest 100 shares. Notwithstanding the foregoing, in no event shall (i) the number of Registrable Securities included in the offering be reduced unless all other
securities (other than securities to be sold by the Company) are first entirely excluded from the offering, and any other securities having contractual registration rights to be included in such offering are reduced on a pro rata basis with the
Registrable Securities, (ii) the number of Registrable Securities included in the offering be reduced below 20% of the total number of securities included in such offering. For purposes of the provision in this Section 2.5(b) concerning
apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members, stockholders, and Affiliates of such Holder, or the estates and immediate family
members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such
“selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,” as defined in this sentence. 

2.6 Effectiveness. After a Registration Statement is effective, if the offering of Registrable Securities pursuant to a
Registration Statement is interfered with by any stop order, injunction or other order or requirement of the SEC or any other governmental agency or court, such Registration Statement will be deemed not to have been effective during the period of
such interference, until the offering of Registrable Securities pursuant to such Registration Statement may legally resume. 

  
 6 

 3. Registration Procedures. In connection with the obligations of the Company with
respect to any Registration Statement, the Company shall: 
 (a) supplement or amend any Registration Statement filed pursuant
to Section 2.1, 2.2 or 2.3 if required by the 1933 Act or the rules and regulations thereunder or by the instructions applicable to the registration form used by the Company or to the extent the Company does not reasonably object, as requested
by Holders with respect to information relating to such Holders covered by such Registration Statement, and to furnish to Holders copies of any such supplement or amendment promptly after it is used or filed with the SEC. 

(b) at a reasonable time, but in no event less than five (5) Business Days prior to filing the Registration Statement, any
Prospectus forming a part thereof, any amendment to the Registration Statement or amendment or supplement to such Prospectus (other than amendments and supplements that do nothing more than name Holders and provide information with respect thereto),
furnish to Holders or any Underwriter or designee thereof and special counsel to Holders or any Underwriter or designee thereof copies of all such documents proposed to be filed and shall consider in good faith the inclusion of such comments as
Holders or any Underwriter or designee thereof and such special counsel to Holders or any Underwriter or designee thereof reasonably shall propose within three (3) Business Days of the delivery of such copies to Holders or any Underwriter or
designee thereof and counsel to Holders or any Underwriter or designee thereof. In addition, if any Holder that has provided the Questionnaire and the other information required by this Agreement shall so request in writing a reasonable time prior
to filing any such documents, the Company shall furnish to such Holder copies of all such documents proposed to be filed and shall consider in good faith the inclusion of such comments as such Holder reasonably shall propose within three Business
Days of the delivery of such copies to such Holder; 
 (c) ensure that (i) the Registration Statement and any amendment
thereto and any Prospectus forming part thereof and any amendment or supplement thereto complies in all material respects with the 1933 Act, and (ii) the Registration Statement and any amendment thereto does not, when it becomes effective,
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; 
 (d) use its reasonable efforts at all times, except as provided in Section 2.2(b), to take all steps necessary to effect and maintain the registration of all of the Registrable Securities covered by
the Registration Statement; 
 (e) use its reasonable efforts to prepare and file with the SEC such amendments and
post-effective amendments to the Registration Statement as may be necessary under applicable law to keep the Registration Statement effective for the Effectiveness Period at all times following such Registration Statement becoming effective, subject
to Section 2.2(b); and cause each Prospectus to be supplemented by any required prospectus supplement, and as so supplemented to be filed in compliance with Rule 424 (or any similar provision then in force) under the 1933 Act and use reasonable
efforts to comply during the Effectiveness Period with the provisions of the 1933 Act, the 1934 Act and the rules and regulations thereunder required to enable the disposition of all Registrable Securities covered by the Registration Statement in
accordance with the intended method or methods of distribution (as provided to the Company in the Questionnaires) by the selling Holders thereof; 
 (f) (i) notify in writing each Holder of Registrable Securities of the filing of a Registration Statement or any post-effective amendment to a Registration Statement and of when any such Registration
Statement or any post-effective amendment to a Registration Statement has become effective, (ii) during the Effectiveness Period, furnish to each Holder of Registrable Securities that has provided the Questionnaires and the information required
by this Agreement and to each Underwriter, if 

  
 7 

 
any, without charge, as many copies of each Prospectus, including each preliminary Prospectus, and any amendment or supplement thereto and such other documents as such Holder or Underwriter may
reasonably request in writing, including financial statements and schedules and, if such Holder or Underwriter so requests, all exhibits thereto in connection with the sale or other disposition of the Registrable Securities, and (iii) subject
to Section 2.2(b) and to any notice by the Company in accordance with Section 3(h) of the existence of any fact of the kind described in Sections 3(h)(i), (ii), (iii), (iv) and (v), hereby consent to the use of the Prospectus or
any amendment or supplement thereto by each of the selling Holders and Underwriters of Registrable Securities that has provided the Questionnaire and the other information required by this Agreement in connection with the offering and sale of the
Registrable Securities covered by such Prospectus or any amendment or supplement thereto in the manner set forth therein; 
 (g)
use its reasonable efforts to register or qualify or cooperate with Holders and Underwriters in connection with the registration or qualification (or exemption from such registration or qualification) of the Registrable Securities under all
applicable state securities or “blue sky” laws of such jurisdictions as any Holder of Registrable Securities covered by a Registration Statement and each Underwriter shall reasonably request in writing, and do any and all other acts and
things which may be reasonably necessary or advisable to maintain such registration or qualification and to enable each such Holder and Underwriter to consummate the disposition in each such jurisdiction of such Registrable Securities owned by such
Holder; provided, however, that the Company shall not be required to (i) qualify as a foreign corporation or as a dealer in securities in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(g), or
(ii) take any action which would subject it to general service of process or taxation in any such jurisdiction where it is not then so subject; 
 (h) notify as promptly as reasonably practicable each Holder of Registrable Securities under a Registration Statement that has provided the Questionnaire and the other information required by this
Agreement and, if requested by such Holder, confirm such advice in writing promptly (i) of any request, following the effectiveness of the Registration Statement under the 1933 Act, by the SEC or any state securities authority for
post-effective amendments and supplements to a Registration Statement and Prospectus or for additional information after the Registration Statement has become effective, (ii) of the issuance by the SEC or any state securities authority of any
stop order suspending the effectiveness of a Registration Statement or the initiation of any proceedings for that purpose, (iii) of the occurrence (but not the nature of or details concerning) of any event or the discovery of any facts during
the period a Registration Statement is effective which makes any statement made in such Registration Statement or the related Prospectus untrue in any material respect or which requires the making of any changes in such Registration Statement or
Prospectus in order to make the statements therein not misleading, (provided, however, that no notice by the Company shall be required pursuant to this clause (iii) in the event that the Company either promptly files a Prospectus supplement to
update the Prospectus or a Form 8-K or other appropriate 1934 Act report that is incorporated by reference into the Registration Statement, which, in either case, contains the requisite information that results in such Registration Statement no
longer containing any untrue statement of material fact or omitting to state a material fact necessary to make the statements therein not misleading), (iv) of the receipt by the Company of any notification with respect to the suspension of the
qualification of the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose, and (v) of any determination by the Company that a post-effective amendment to such Registration
Statement would be required by applicable law; 
 (i) use reasonable efforts to promptly notify Holders (i) of receipt of
any comment letters received from the SEC with respect to a Registration Statement or any documents incorporated therein and (ii) any other request by the SEC or any state securities authority for amendments or supplements to a Registration
Statement and Prospectus or for additional information with respect to the Registration Statement and Prospectus; 

  
 8 

 (j) use its reasonable efforts to obtain the withdrawal of any order suspending the
effectiveness of a Registration Statement or the qualification of the securities therein for sale in any jurisdiction at the earliest practicable moment or, if any such order or suspension is made effective during any Suspension Period, at the
earliest practicable moment after the Suspension Period; 
 (k) upon the occurrence of any event or the discovery of any facts,
each as contemplated by Sections 3(h)(i), (ii), (iii), (iv) and (v), as promptly as practicable after the occurrence of such an event, use reasonable efforts to prepare a supplement or post-effective amendment to the Registration Statement
or the related Prospectus or any document incorporated therein by reference or file any other required document so that, as thereafter delivered to the purchasers of the Registrable Securities, such Prospectus will not contain at the time of such
delivery any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. At such time as such public disclosure is otherwise
made or the Company determines that such disclosure is not necessary, in each case to correct any misstatement of a material fact or to include any omitted material fact, the Company agrees promptly to notify each Holder that has provided the
Questionnaire and the other information required by this Agreement of such determination and to furnish each Holder such number of copies of the Prospectus as amended or supplemented, as such Holder may reasonably request; 

(l) use (i) its best efforts to maintain the listing of the Common Stock on The NASDAQ Global Select Market or another “Trading
Market” (as defined in the Warrants) and (ii) use its best efforts to cause all Registrable Securities to be listed on any securities exchange or inter-dealer quotation system on which similar securities issued by the Company are then
listed or quoted; 
 (m) in the event of any underwritten public offering, enter into and perform its obligations under an
underwriting agreement in order to expedite or facilitate the disposition of the Registrable Securities, in usual and customary form, with the Underwriter(s) of such offering; 
 (n) make available, during normal business hours, for inspection by any selling Holder, any Underwriter participating in any disposition pursuant to the Registration Statement and any attorney, accountant
or other agent retained by any such selling Holder or Underwriter, financial and other records, pertinent corporate documents and properties of the Company, and cause the Company’s officers, directors, employees and independent accountants to
supply information requested by any such selling Holder, Underwriter, attorney, accountant or agent in each case in connection with, and only to the extent reasonably necessary in connection with, the preparation and filing of, such Registration
Statement (subject to execution by any such party of a confidentiality agreement in customary form reasonably satisfactory to the Company); and 
 (o) use its reasonable efforts effort to provide such information as is required for any filings required to be made with the Financial Industry Regulatory Authority, Inc. 

Without limiting the provisions of Section 2.2(d), the Company may (as a condition to such Holder’s participation in the Registration
Statement) require each Holder of Registrable Securities to furnish to the Company such information regarding such Holder and the proposed distribution by such Holder of such Registrable Securities as the Company may from time to time reasonably
request in writing. Each Holder agrees promptly to furnish to the Company in writing all information required to be disclosed in order to make the information previously furnished to the Company by such Holder not misleading, any other information
regarding such Holder and the distribution of such Registrable Securities as may be required to be disclosed in the Prospectus or Registration Statement under applicable law or pursuant to SEC comments and any information otherwise reasonably
required by the Company to comply with applicable law or regulations. 

  
 9 

 Each Holder agrees that, unless it obtains the prior written consent of the Company, it will not make any
offer relating to the Registrable Securities that would constitute an Issuer Free Writing Prospectus, or that would otherwise constitute a Free Writing Prospectus required to be filed with the SEC. The Company represents that any Issuer Free Writing
Prospectus authorized by it in writing for use by such Holder will be delivered to each such Holder and will not include any information that conflicts with the information contained in the Registration Statement or the Prospectus and, any such
Issuer Free Writing Prospectus, when taken together with the information in the Registration Statement and the Prospectus, will not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading. 
 Each Holder agrees that, upon receipt of any
notice from the Company of the happening of any event or the discovery of any facts, each of the kind described in Section 3(h)(i), (ii), (iii), (iv) and (v), such Holder will forthwith discontinue disposition of Registrable Securities
pursuant to the Prospectus included in the Registration Statement until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 3(k) or written notice from the Company that the Registration
Statement is again effective and no amendment or supplement is needed, and, if so directed by the Company, such Holder will deliver to the Company all copies in such Holder’s possession, other than permanent file copies then in such
Holder’s possession, of the Prospectus covering such Registrable Securities at the time of receipt of such notice. 
 4.
Indemnification; Contribution. 
 4.1 Indemnification by the Company. The Company agrees to indemnify and hold
harmless each Holder and each of their respective directors, officers and employees and agents and each Person, if any, who controls such Holder within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act (each of the
foregoing is referred to herein as an “indemnified party”) (i) against any loss, claim, damage, liability or expense to which such indemnified party may become subject, insofar as such loss, claim, damage, liability or expense
(or actions in respect thereof as contemplated below) arises out of or is based upon (x) any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement (or any amendment or supplement thereto),
including all documents incorporated therein by reference, or the omission or alleged omission therefrom of a material fact, in each case, necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading, (y) any untrue statement or alleged untrue statement of a material fact contained in any preliminary prospectus or the Prospectus (or any amendment or supplement thereto), including all documents incorporated therein by
reference, or the omission or alleged omission therefrom of a material fact, in each case, necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (z) any untrue
statement or alleged untrue statement of a material fact contained in any Issuer Free Writing Prospectus prepared by it or authorized by it in writing for use by such Holder (or any amendment or supplement thereto), or the omission or alleged
omission therefrom of a material fact, in each case, necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; (ii) against any and all loss, liability, claim, damage and
expense whatsoever to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever, as incurred, based upon any
such untrue statement or omission, or any such alleged untrue statement or omission; provided, that (subject to Section 4.4) any such settlement is effected with the written consent of the Company; and (iii) against any and all reasonable
out-of-pocket expense whatsoever, as incurred (including the reasonable fees and disbursements of counsel chosen by such indemnified party), reasonably incurred in investigating, 

  
 10 

 
preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue
statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under subparagraph (i) or (ii) above; provided, however, that the foregoing indemnity agreement shall not apply to any
loss, claim, damage, liability or expense incurred to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with
written information furnished to the Company by such indemnified party expressly for use in the Registration Statement (or any amendment or supplement thereto), any preliminary prospectus or the Prospectus (or any amendment or supplement thereto) or
any Issuer Free Writing Prospectus (or any amendment or supplement thereto). The indemnity agreement set forth in this Section 4.1 shall be in addition to any liabilities that the Company may otherwise have. 

4.2 Indemnification by Holders. Each Holder severally, but not jointly, agrees to indemnify and hold harmless the Company, each
other Holder, and each of their respective directors, officers, employees and agents and each Person, if any, who controls the Company or any other Holder within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act,
against any and all loss, liability, claim, damage and expense described in the indemnity contained in Section 4.1, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions, made in any Registration
Statement (or any amendment thereto), any preliminary prospectus or the Prospectus included therein (or any amendment or supplement thereto) or any Issuer Free Writing Prospectus (or any amendment or supplement thereto) in reliance upon and in
conformity with written information with respect to such Holder furnished to the Company by or on behalf of such Holder expressly for use in such Registration Statement (or any amendment thereto), such preliminary prospectus or the Prospectus (or
any amendment or supplement thereto) or any Issuer Free Writing Prospectus (or any amendment or supplement thereto). 
 4.3
Notifications and Other Indemnification Procedures. Promptly after receipt by an indemnified party under this Section 4 of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made
against an indemnifying party under this Section 4, notify the indemnifying party in writing of the commencement thereof, but the failure to so notify the indemnifying party (1) will not relieve it from liability under Sections 4.1 and 4.2
unless and to the extent it did not otherwise learn of such action and such failure materially prejudices the indemnifying party and (2) will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other
than the indemnification obligation provided in this Section 4. In case any such action is brought against any indemnified party and such indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party
will be entitled to participate in, and, to the extent that it shall elect, jointly with all other indemnifying parties similarly notified, by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such
indemnified party, to assume the defense thereof with counsel reasonably satisfactory to such indemnified party; provided, however, if the defendants in any such action include both the indemnified party and the indemnifying party and the
indemnified party shall have reasonably concluded that a conflict may arise between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available to it
and/or other indemnified parties that are different from or additional to those available to the indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise
participate in the defense of such action on behalf of such indemnified party or parties. Upon receipt of notice from the indemnifying party to such indemnified party of such indemnifying party’s election to assume the defense of such action
and approval by the indemnified party of counsel, the indemnifying party will not be liable to such indemnified party under this Section 4 for any legal or other expenses subsequently incurred by such indemnified party in connection with the
defense thereof unless (i) the indemnified party shall have employed separate counsel in accordance with the proviso to the preceding sentence (it being understood, 

  
 11 

 
however, that the indemnifying party shall not be liable for the expenses of more than one separate counsel (other than local counsel), reasonably approved by the indemnifying party, representing
the indemnified parties who are parties to such action) or (ii) the indemnifying party shall not have employed counsel satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of
commencement of the action, in each of which cases the fees and expenses of counsel shall be at the expense of the indemnifying party. 
 4.4 Settlements. The indemnifying party under this Section 4 shall not be liable for any settlement of any proceeding effected without its written consent, which shall not be unreasonably
withheld or delayed, but if settled with such consent or if there is a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense by reason of such
settlement or judgment. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect
of which any indemnified party is or could have been a party and indemnity was or could have been sought hereunder by such indemnified party, unless such settlement, compromise or consent includes an unconditional release of such indemnified party
from all liability on claims that are the subject matter of such action, suit or proceeding and does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. 

If the indemnification provided for in this Section 4 is for any reason unavailable to or insufficient to hold harmless an indemnified party in
respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party,
as incurred, in such proportion as is appropriate to reflect the relative fault of the Company on the one hand and Holders on the other hand in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages
or expenses, as well as any other relevant equitable considerations. 
 The relative fault of the indemnifying parties on the one hand and the
indemnified parties and Holders on the other hand shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to
information supplied by the Company, or by Holders and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
 The Company and Holders agree that it would not be just and equitable if contribution pursuant to this Section 4 were determined by pro rata allocation or by any other method of allocation which does
not take account of the equitable considerations referred to above in this Section 4. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section 4 shall
be deemed to include any reasonable out-of-pocket legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or
body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission. 

Notwithstanding the provisions of this Section 4, no Holder shall be required to indemnify or contribute any amount in excess of the amount by which
the total price at which the Registrable Securities sold by such Holder exceeds the amount of any damages which such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

 No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to contribution
from any Person who was not guilty of such fraudulent misrepresentation. 

  
 12 

 For purposes of this Section 4, each director, officer, employee and agent of Holder, or each Person,
if any, who controls any Holder within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as such Holder, and each director, officer, employee or agent of the Company, and
each Person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Company. 

The provisions of this Section 4 shall remain in full force and effect, regardless of any investigation made by or on behalf of any Holder or the
Company or any indemnified person referred to in this Section 4, and shall survive the sale by a Holder of Registrable Securities covered by such Registration Statement. 
 5. Rule 144. With a view to making available to Holders of Registrable Securities the benefits of Rule 144, the Company covenants that during the Effectiveness Period it will (i) file all
reports and other documents required, if any, to be filed by it under the 1933 Act and the 1934 Act and the rules and regulations adopted thereunder and (ii) make available information necessary to comply with Rule 144 at all times, all to the
extent required from time to time to enable such Holder to sell Registrable Securities without registration under the 1933 Act within the limitations of the exemption provided by Rule 144. If at any time the Company is not subject to the reporting
requirements of the 1934 Act, it will make available other information as required by, and so long as necessary to permit sales of Registrable Securities pursuant to, Rule 144. 

6. Miscellaneous. 
 6.1 No Inconsistent Agreements. The Company has not entered into and the Company will not after the date of this Agreement enter into any agreement with respect to its securities which conflicts
with the rights granted to Holders of Registrable Securities in this Agreement. The rights granted to Holders hereunder do not for the term of this Agreement conflict with the rights granted to the holders of the Company’s other issued and
outstanding securities under any such agreements. 
 6.2 Amendments and Waivers. The provisions of this Agreement may not
be amended, qualified, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the Company has obtained the written consent of the Majority Holders. Notwithstanding the foregoing,
(i) a waiver or consent to departure from the provisions hereof with respect to a matter that relates exclusively to the rights of Holders whose Registrable Securities are being sold pursuant to a Registration Statement and that does not
directly or indirectly affect the rights of other Holders may be given by the Majority Holders, determined on the basis of the Registrable Securities being sold under such Registration Statement and (ii) this Agreement may be amended by a
written agreement between the Company and Initial Holders, without the consent otherwise of Holders of the Registrable Securities, in order to cure any ambiguity or to correct or supplement any provision contained herein; provided, that no such
amendment shall adversely affect the interest of Holders of Registrable Securities. Each Holder of Registrable Securities outstanding at the time of any amendment, modification, waiver or consent pursuant to this Section 6.2 shall be bound by
such amendment, modification, waiver or consent, whether or not any notice or writing indicating such amendment, modification, waiver or consent is delivered to such Holder. 
 6.3 Notices. Any notices or other communications required or permitted to be given hereunder shall be in writing and shall be deemed to be given when delivered in person or by private courier with
receipt, if faxed when verbal or email confirmation from the recipient is received, or three (3) days after being deposited in the United States mail, first-class, registered or certified, return receipt requested, with postage paid. All
communications shall be sent to the Company and the Initial Holders at the addresses set forth in the Credit Agreement and to any other Holder at such address indicated in writing to the Company by such Holder. The Company and any Holder may change
the address to which notices and communications to it are to be addressed by notification as provided herein. 

  
 13 

 6.4 Successor and Assigns. This Agreement shall inure to the benefit of and be
binding upon the successors, assigns and transferees of each of the parties, including, without limitation and without the need for an express assignment, subsequent Holders. If any transferee of any Holder shall acquire Registrable Securities, in
any manner, whether by operation of law or otherwise, such Registrable Securities shall be held subject to all of the terms of this Agreement, and by taking and holding such Registrable Securities such person shall be conclusively deemed to have
agreed to be bound by and to perform all of the terms and provisions of this Agreement, including the restrictions on resale set forth in this Agreement, and such person shall be entitled to receive the benefits hereof. 

6.5 Third Party Beneficiaries. Each Holder of Registrable Securities shall be a third party beneficiary to the agreements made
hereunder between the Company, on the one hand, and Initial Holders, on the other hand, and shall have the right to enforce such agreements directly to the extent it deems such enforcement necessary or advisable to protect its rights hereunder.

 6.6 Specific Enforcement. Without limiting the remedies available to Holders, the Company acknowledges that any
failure by the Company to comply with its obligations under this Agreement may result in material irreparable injury to Holders for which there is no adequate remedy at law, that it may not be possible to measure damages for such injuries precisely
and that, in the event of any such failure, any Holder may seek such relief as may be required to specifically enforce the Company’s obligations under this Agreement. 
 6.7 Counterparts. This Agreement may be signed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. 

6.8 Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the
meaning hereof. 
 6.9 Governing Law. 
 (a) This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware. 
 (b) Each of the parties hereto irrevocably and unconditionally: (i) submits for itself and its property in any legal action or proceeding relating solely to this Agreement or the transactions
contemplated hereby, to the exclusive jurisdiction of the courts of the State of Delaware and the Federal courts of the United States of America located within the State of Delaware, and appellate courts thereof; (ii) consents that any such
action or proceeding may be brought in such courts, and waives any objection that it may now or hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and
agrees not to plead or claim the same to the extent permitted by applicable law; (iii) agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail (or any
substantially similar form of mail), postage prepaid, to the party, as the case may be, at its address in accordance with Section 6.3 or at such other address of which the other party shall have been notified in writing pursuant thereto;
(iv) agrees that nothing herein shall affect the right to effect service of process in any other manner permitted by law or shall limit the right to sue in any other jurisdiction for recognition and enforcement of any judgment or if
jurisdiction in the courts referenced in the foregoing clause (i) are not available despite the intentions of the parties hereto; (v) agrees that final judgment in any such suit, action or proceeding brought in such a court may be enforced
in the courts of any jurisdiction to which such party is subject by a suit upon such judgment, provided that service of process is effected upon such party 

  
 14 

 
in the manner specified herein or as otherwise permitted by law; (vi) agrees that to the extent that such party has or hereafter may acquire any immunity from jurisdiction of any court or
from any legal process with respect to itself or its property, such party hereby irrevocably waives such immunity in respect of its obligations under this Agreement, to the extent permitted by law; and (vii) irrevocably and unconditionally
waives trial by jury in any legal action or proceeding in relation to this Agreement. 
 6.10 Severability. If any part
or provision of this Agreement is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction, the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent
possible, the original business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding upon the parties hereto. 

6.11 Entire Agreement. This Agreement, the Warrants and the other Loan Documents, constitute the entire agreement between the
parties hereto respecting the subject matter hereof and supersedes all prior agreements, negotiations, understandings, representations and statements respecting the subject matter hereof, whether written or oral. 

[Signature Page Follows] 

  
 15 

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as
of the date first written above. 
  

			
	POWERWAVE TECHNOLOGIES, INC.
		
	By:	 	 /s/ Kevin T. Michaels

	Name:	 	Kevin T. Michaels
	Title:	 	Chief Financial Officer

  
 S-1

 PWAV – Registration Rights Agreement 

 Confirmed and accepted on behalf of Holders as of the date first written above: 

 

			
	P-WAVE HOLDINGS, LLC
		
	By:	 	 /s/ Steven G. Eisner

		 	Steven G. Eisner
		 	Vice President

  
 S-2

 PWAV – Registration Rights Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00209-of-00352.parquet"}]]